Polypill for Cardiovascular Disease Prevention in an Underserved Population
- PMID: 31875510
- PMCID: PMC8258867
- DOI: 10.1056/NEJMc1914047
Polypill for Cardiovascular Disease Prevention in an Underserved Population
Conflict of interest statement
Comment in
-
Polypill for Cardiovascular Disease Prevention in an Underserved Population. Reply.N Engl J Med. 2020 Jan 2;382(1):95. doi: 10.1056/NEJMc1914047. N Engl J Med. 2020. PMID: 31875511 Free PMC article. No abstract available.
Comment on
-
Polypill for Cardiovascular Disease Prevention in an Underserved Population.N Engl J Med. 2019 Sep 19;381(12):1114-1123. doi: 10.1056/NEJMoa1815359. N Engl J Med. 2019. PMID: 31532959 Free PMC article. Clinical Trial.
References
-
- Roshandel G, Khoshnia M, Poustchi H, et al.Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet. 2019;394:672–683. - PubMed
-
- Link BG, Phelan J. Social Conditions As Fundamental Causes of Disease. J Health Soc Behav 1995;35:80–94. - PubMed
-
- Salami JA, Warraich H, Valero-Elizondo J, et al.National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey. JAMA Cardiol. 2017;2:56–65. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources